United States Cell-Free Fetal DNA Testing Market Report 2017
- QYR895362
- 122 Pages
- January 2017
- Medical Devices
Sales, means the sales volume of Cell-Free Fetal DNA Testing
Revenue, means the sales value of Cell-Free Fetal DNA Testing
This report studies sales (consumption) of Cell-Free Fetal DNA Testing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Sequenom Laboratories
Illumina
Ariosa Diagnostics
Arup Laboratories
The Fetal Medicine Center
Apollo Path labs
Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Detection of Abnormal Chromosome Number
Gender Testing
Paternally Inherited Disorders
Split by applications, this report focuses on sales, market share and growth rate of Cell-Free Fetal DNA Testing in each application, can be divided into
Hospitals
Ambulatory Surgical Centers
Others
United States Cell-Free Fetal DNA Testing Market Report 2017
1 Cell-Free Fetal DNA Testing Overview
1.1 Product Overview and Scope of Cell-Free Fetal DNA Testing
1.2 Classification of Cell-Free Fetal DNA Testing
1.2.1 Detection of Abnormal Chromosome Number
1.2.2 Gender Testing
1.2.3 Paternally Inherited Disorders
1.3 Application of Cell-Free Fetal DNA Testing
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Cell-Free Fetal DNA Testing (2012-2022)
1.4.1 United States Cell-Free Fetal DNA Testing Sales and Growth Rate (2012-2022)
1.4.2 United States Cell-Free Fetal DNA Testing Revenue and Growth Rate (2012-2022)
2 United States Cell-Free Fetal DNA Testing Competition by Manufacturers
2.1 United States Cell-Free Fetal DNA Testing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cell-Free Fetal DNA Testing Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cell-Free Fetal DNA Testing Average Price by Manufactures (2015 and 2016)
2.4 Cell-Free Fetal DNA Testing Market Competitive Situation and Trends
2.4.1 Cell-Free Fetal DNA Testing Market Concentration Rate
2.4.2 Cell-Free Fetal DNA Testing Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Cell-Free Fetal DNA Testing Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Cell-Free Fetal DNA Testing Sales and Market Share by States (2012-2017)
3.2 United States Cell-Free Fetal DNA Testing Revenue and Market Share by States (2012-2017)
3.3 United States Cell-Free Fetal DNA Testing Price by States (2012-2017)
4 United States Cell-Free Fetal DNA Testing Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Cell-Free Fetal DNA Testing Sales and Market Share by Type (2012-2017)
4.2 United States Cell-Free Fetal DNA Testing Revenue and Market Share by Type (2012-2017)
4.3 United States Cell-Free Fetal DNA Testing Price by Type (2012-2017)
4.4 United States Cell-Free Fetal DNA Testing Sales Growth Rate by Type (2012-2017)
5 United States Cell-Free Fetal DNA Testing Sales (Volume) by Application (2012-2017)
5.1 United States Cell-Free Fetal DNA Testing Sales and Market Share by Application (2012-2017)
5.2 United States Cell-Free Fetal DNA Testing Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Cell-Free Fetal DNA Testing Manufacturers Profiles/Analysis
6.1 Sequenom Laboratories
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cell-Free Fetal DNA Testing Product Type, Application and Specification
6.1.2.1 Detection of Abnormal Chromosome Number
6.1.2.2 Gender Testing
6.1.3 Sequenom Laboratories Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Illumina
6.2.2 Cell-Free Fetal DNA Testing Product Type, Application and Specification
6.2.2.1 Detection of Abnormal Chromosome Number
6.2.2.2 Gender Testing
6.2.3 Illumina Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Ariosa Diagnostics
6.3.2 Cell-Free Fetal DNA Testing Product Type, Application and Specification
6.3.2.1 Detection of Abnormal Chromosome Number
6.3.2.2 Gender Testing
6.3.3 Ariosa Diagnostics Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Arup Laboratories
6.4.2 Cell-Free Fetal DNA Testing Product Type, Application and Specification
6.4.2.1 Detection of Abnormal Chromosome Number
6.4.2.2 Gender Testing
6.4.3 Arup Laboratories Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 The Fetal Medicine Center
6.5.2 Cell-Free Fetal DNA Testing Product Type, Application and Specification
6.5.2.1 Detection of Abnormal Chromosome Number
6.5.2.2 Gender Testing
6.5.3 The Fetal Medicine Center Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Apollo Path labs
6.6.2 Cell-Free Fetal DNA Testing Product Type, Application and Specification
6.6.2.1 Detection of Abnormal Chromosome Number
6.6.2.2 Gender Testing
6.6.3 Apollo Path labs Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
7 Cell-Free Fetal DNA Testing Manufacturing Cost Analysis
7.1 Cell-Free Fetal DNA Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cell-Free Fetal DNA Testing
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cell-Free Fetal DNA Testing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cell-Free Fetal DNA Testing Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Cell-Free Fetal DNA Testing Market Forecast (2017-2022)
11.1 United States Cell-Free Fetal DNA Testing Sales, Revenue Forecast (2017-2022)
11.2 United States Cell-Free Fetal DNA Testing Sales Forecast by Type (2017-2022)
11.3 United States Cell-Free Fetal DNA Testing Sales Forecast by Application (2017-2022)
11.4 Cell-Free Fetal DNA Testing Price Forecast (2017-2022)
12 Research Findings and Conclusion
13 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Cell-Free Fetal DNA Testing
Table Classification of Cell-Free Fetal DNA Testing
Figure United States Sales Market Share of Cell-Free Fetal DNA Testing by Type in 2015
Figure Detection of Abnormal Chromosome Number Picture
Figure Gender Testing Picture
Figure Paternally Inherited Disorders Picture
Table Application of Cell-Free Fetal DNA Testing
Figure United States Sales Market Share of Cell-Free Fetal DNA Testing by Application in 2015
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Others Examples
Figure United States Cell-Free Fetal DNA Testing Sales and Growth Rate (2012-2022)
Figure United States Cell-Free Fetal DNA Testing Revenue and Growth Rate (2012-2022)
Table United States Cell-Free Fetal DNA Testing Sales of Key Manufacturers (2015 and 2016)
Table United States Cell-Free Fetal DNA Testing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cell-Free Fetal DNA Testing Sales Share by Manufacturers
Figure 2016 Cell-Free Fetal DNA Testing Sales Share by Manufacturers
Table United States Cell-Free Fetal DNA Testing Revenue by Manufacturers (2015 and 2016)
Table United States Cell-Free Fetal DNA Testing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cell-Free Fetal DNA Testing Revenue Share by Manufacturers
Table 2016 United States Cell-Free Fetal DNA Testing Revenue Share by Manufacturers
Table United States Market Cell-Free Fetal DNA Testing Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cell-Free Fetal DNA Testing Average Price of Key Manufacturers in 2015
Figure Cell-Free Fetal DNA Testing Market Share of Top 3 Manufacturers
Figure Cell-Free Fetal DNA Testing Market Share of Top 5 Manufacturers
Table United States Cell-Free Fetal DNA Testing Sales by States (2012-2017)
Table United States Cell-Free Fetal DNA Testing Sales Share by States (2012-2017)
Figure United States Cell-Free Fetal DNA Testing Sales Market Share by States in 2015
Table United States Cell-Free Fetal DNA Testing Revenue and Market Share by States (2012-2017)
Table United States Cell-Free Fetal DNA Testing Revenue Share by States (2012-2017)
Figure Revenue Market Share of Cell-Free Fetal DNA Testing by States (2012-2017)
Table United States Cell-Free Fetal DNA Testing Price by States (2012-2017)
Table United States Cell-Free Fetal DNA Testing Sales by Type (2012-2017)
Table United States Cell-Free Fetal DNA Testing Sales Share by Type (2012-2017)
Figure United States Cell-Free Fetal DNA Testing Sales Market Share by Type in 2015
Table United States Cell-Free Fetal DNA Testing Revenue and Market Share by Type (2012-2017)
Table United States Cell-Free Fetal DNA Testing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cell-Free Fetal DNA Testing by Type (2012-2017)
Table United States Cell-Free Fetal DNA Testing Price by Type (2012-2017)
Figure United States Cell-Free Fetal DNA Testing Sales Growth Rate by Type (2012-2017)
Table United States Cell-Free Fetal DNA Testing Sales by Application (2012-2017)
Table United States Cell-Free Fetal DNA Testing Sales Market Share by Application (2012-2017)
Figure United States Cell-Free Fetal DNA Testing Sales Market Share by Application in 2015
Table United States Cell-Free Fetal DNA Testing Sales Growth Rate by Application (2012-2017)
Figure United States Cell-Free Fetal DNA Testing Sales Growth Rate by Application (2012-2017)
Table Sequenom Laboratories Basic Information List
Table Sequenom Laboratories Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sequenom Laboratories Cell-Free Fetal DNA Testing Sales Market Share (2012-2017)
Table Illumina Basic Information List
Table Illumina Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Illumina Cell-Free Fetal DNA Testing Sales Market Share (2012-2017)
Table Ariosa Diagnostics Basic Information List
Table Ariosa Diagnostics Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ariosa Diagnostics Cell-Free Fetal DNA Testing Sales Market Share (2012-2017)
Table Arup Laboratories Basic Information List
Table Arup Laboratories Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Arup Laboratories Cell-Free Fetal DNA Testing Sales Market Share (2012-2017)
Table The Fetal Medicine Center Basic Information List
Table The Fetal Medicine Center Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table The Fetal Medicine Center Cell-Free Fetal DNA Testing Sales Market Share (2012-2017)
Table Apollo Path labs Basic Information List
Table Apollo Path labs Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Apollo Path labs Cell-Free Fetal DNA Testing Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cell-Free Fetal DNA Testing
Figure Manufacturing Process Analysis of Cell-Free Fetal DNA Testing
Figure Cell-Free Fetal DNA Testing Industrial Chain Analysis
Table Raw Materials Sources of Cell-Free Fetal DNA Testing Major Manufacturers in 2015
Table Major Buyers of Cell-Free Fetal DNA Testing
Table Distributors/Traders List
Figure United States Cell-Free Fetal DNA Testing Production and Growth Rate Forecast (2017-2022)
Figure United States Cell-Free Fetal DNA Testing Revenue and Growth Rate Forecast (2017-2022)
Table United States Cell-Free Fetal DNA Testing Production Forecast by Type (2017-2022)
Table United States Cell-Free Fetal DNA Testing Consumption Forecast by Application (2017-2022)
Table United States Cell-Free Fetal DNA Testing Sales Forecast by States (2017-2022)
Table United States Cell-Free Fetal DNA Testing Sales Share Forecast by States (2017-2022)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
